Jeffrey Humphrey's Net Worth

$176 Thousand

Estimate Recalculated Feb 12, 2025 10:17PM EST

Who is Jeffrey Humphrey

Jeffrey Humphrey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Magenta Therapeutics, Inc., Cyteir Therapeutics, Inc., and Lantheus Holdings, Inc..

SEC CIK

Jeffrey Humphrey's CIK is 0001816944

Past Insider Trading and Trends

2022 was Jeffrey Humphrey's most active year for acquiring shares with 4 total transactions. Jeffrey Humphrey's most active month to acquire stocks was the month of January. 2021 was Jeffrey Humphrey's most active year for disposing of shares, totalling 2 transactions. Jeffrey Humphrey's most active month to dispose stocks was the month of June. 2024 saw Jeffrey Humphrey paying a total of $749,949.88 for 25,264 shares, this is the most they've acquired in one year. In 2021 Jeffrey Humphrey cashed out on 168,055 shares for a total of $0.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CONSTELLATION PHARMACEUTICALS INC

Chief Medical Officer
Updated Jul 19, 2021
Jul 15
35.06KFeb 16
133.00KJul 07
Showing 4 results

Magenta Therapeutics, Inc.

Chief Medical Officer
Updated Aug 01, 2022
75.00KAug 01
50.00KMay 17
75.00KFeb 15
275.00KOct 01
Showing 5 results

Cyteir Therapeutics, Inc.

Investor
Updated Feb 07, 2023
14.15KFeb 03
2.36KFeb 22
28.30KDec 15
Showing 4 results

Lantheus Holdings, Inc.

Chief Medical Officer
Updated Jun 20, 2024
Jun 17
Showing 2 results